Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatology Other
    Phenytoin, Fosphenytoin May Increase Risk of Serious Skin Reactions in Asian Patients With HLA-B*1502 Allele - (DGNews)
    Swissmedic Approves Ceftobiprole Medocaril for Treatment of Complicated Skin Structure Infections - (DGNews)
    Subcutaneous Ecallantide Effective for Treatment of Acute Hereditary Angio-Oedema Episodes: Presented at ACAAI - (DGDispatch)
    Uremic Pruritus Impairs Key Aspects of Quality of Life in Hemodialysis Patients: Presented at ASN - (DGDispatch)
    New Method Estimates Radiation Skin Doses During CT-Guided Interventional Procedures - (DGNews)

    News archive

     Recent webcasts/CME - Dermatology Other
    • Moving Beyond Standard Therapy in Malignant Melanoma: Novel Agents and Combinations
    • Adjuvant Interferon Therapy Prolongs Relapse-Free Interval and Survival in Melanoma
    • Maintenance Debridement in the Treatment of Difficult-to-Heal Chronic Wounds
      Eradicating Lice: Myths and Facts
      Sunburn: The Summertime Blues

      Webcasts/CME archive

       Recent cases - Dermatology Other
        Painless Pink Papules with Central Porcelain-white Scars
        Dermatomyositis and Supraventricular Tachycardia
        Sweet Syndrome During Pregnancy
        Multiple Papillae on Labia Minoraa
        Sister Mary Joseph's Nodule: Three Case Reports

        Cases archive
          




        my personal edition > dermatology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Tretinoin Emollient Cream Safe And Effective for Long-Term Treatment of Wrinkles and Hyperpigmentation: Presented at AAD

        By Alison Palkhivala

        SAN FRANCISCO, CA -- March 26, 2003 -- Long-term use of 0.05% tretinoin emollient cream safely improves the problems associated with photodamaged skin, such as wrinkling and mottled hyperpigmentation, according to a multicentre study.

        Lead researcher Sewong Kang, MD, from the department of dermatology, University of Michigan, Ann Arbor, United States, presented the findings here on March 22nd at the 61st Annual Meeting of the American Academy of Dermatology.

        The study included 204 patients aged 30 to 75 with lightly pigmented and/or moderate to severe photodamaged skin, who were randomised to treatment with a 0.05% tretinoin emollient cream or a vehicle alone (placebo).

        Among the 160 patients who completed the 24-month treatment period, those using the tretinoin cream had significantly better improvements than those who used the placebo with respect to fine wrinkling and mottled hyperpigmentation (p=0.002 for both). There was no difference between the two groups with respect to tactile roughness.

        In terms of secondary end points, the tretinoin cream was also significantly superior to placebo with respect to improving coarse wrinkling (p=0.029), sallowness (p=0.008) and lentigines (p=0.006). Physicians' global assessment was also superior for patients using the tretinoin cream rather than the placebo (p=0.002).

        The most common adverse event associated with use of the tretinoin cream was mild cutaneous irritation, which peaked at 2 months.

        Based on these findings, the authors concluded that a tretinoin 0.05% cream offers long-term safety and efficacy for the treatment of fine wrinkles, mottled hyperpigmentation, coarse wrinkles, sallowness and lentigines in patients with moderate to severe photodamaged skin.

        Ortho Neutrogena sponsored the study.


        [Study title: Safety and Efficacy of Long-Term Use of Tretinoin Emolient Cream 0.05% for the Treatment of Photodamaged Facial Skin: Review of a Clinical Trial. Abstract p100]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send